Fluorescent marks for use in medical devices (Q11207)

From EU Knowledge Graph
Revision as of 15:27, 22 October 2020 by DG Regio (talk | contribs) (‎Removed claim: summary (P836): The project is aimed at R & D for the preparation of specific fluorescent marks, so-called tandem fluorochroms, to enable the production of a product group — In vitro diagnostic (IVD) medical devices to identify malignant, reactive and normal blood cells in clinical samples by flow cytometry. Compliance with the requirements of regulation 21 CFR 820 will guarantee the possibility of registering new products for clinical applications in global...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Fluorescent marks for use in medical devices
Project in Czech Republic financed by DG Regio

    Statements

    country
    Czechia
    0 references
    EU contribution
    4,208,983.49 Czech koruna
    0 references
    168,359.34 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    budget
    10,525,090.0 Czech koruna
    0 references
    421,003.60 Euro
    exchange rate to Euro
    0.04 Euro
    point in time
    10 January 2020
    0 references
    co-financing rate
    39.99 percent
    0 references
    start time
    20 April 2017
    0 references
    expected end time
    18 April 2020
    0 references
    beneficiary name (string)
    EXBIO Praha, a.s.
    0 references
    beneficiary
    Q197450
    0 references
    coordinate location

    49°59'0.49"N, 14°30'9.11"E
    0 references
    postal code
    25250
    0 references
    summary
    Projekt je zaměřen na VaV technologie přípravy specifických fluorescenčních značek, tzv. tandemových fluorochromů, která umožní výrobu skupiny produktů - In vitro diagnostických (IVD) zdravotnických prostředků pro identifikaci maligních, reaktivních a normálních krevních buněk v klinických vzorcích pomocí průtokové cytometrie. Splněním požadavků regulace 21 CFR 820 bude zaručena možnost registrace nových produktů pro klinické aplikace na celosvětových trzích, včetně USA. a. (Czech)
    0 references

    Identifiers

    Czech Kohesio ID
    CZ.01.1.02/0.0/0.0/16_083/0010233
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q11207&oldid=6598719"